SOUTH SAN FRANCISCO, CA--(Marketwire - June 03, 2010) - Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at three upcoming conferences:
-
9th Annual Needham Healthcare Conference
Wednesday, June 9 at 10:40 a.m. EDT
New York Palace Hotel, New York City -
Jefferies 2010 Global Life Sciences Conference
Thursday, June 10 at 8:00 a.m. EDT
Grand Hyatt, New York City -
ThinkEquity Mid Year Check-Up on Healthcare
Wednesday, June 16 at 11:30 a.m. EDT
The Princeton Club, New York City
A live webcast of the Jefferies presentation on June 10th will be available on the Sunesis website at http://ir.sunesis.com. A replay of that webcast will be archived on the “Calendar of Events” page in the Investors and Media section of the Sunesis website for two weeks following the presentation.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis, please visit http://www.sunesis.com.
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries:
Andrea Rabney
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
